Annual FCF
-$12.45 M
-$4.86 M-63.92%
December 31, 2023
Summary
- As of February 7, 2025, ATXI annual free cash flow is -$12.45 million, with the most recent change of -$4.86 million (-63.92%) on December 31, 2023.
- During the last 3 years, ATXI annual FCF has fallen by -$6.84 million (-121.82%).
- ATXI annual FCF is now -662.93% below its all-time high of -$1.63 million, reached on December 31, 2016.
Performance
ATXI Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.89 M
-$636.00 K-28.23%
September 30, 2024
Summary
- As of February 7, 2025, ATXI quarterly free cash flow is -$2.89 million, with the most recent change of -$636.00 thousand (-28.23%) on September 30, 2024.
- Over the past year, ATXI quarterly FCF has dropped by -$565.00 thousand (-24.31%).
- ATXI quarterly FCF is now -8397.06% below its all-time high of -$34.00 thousand, reached on March 31, 2017.
Performance
ATXI Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$10.59 M
-$1.00 M-10.43%
September 30, 2024
Summary
- As of February 7, 2025, ATXI TTM free cash flow is -$10.59 million, with the most recent change of -$1.00 million (-10.43%) on September 30, 2024.
- Over the past year, ATXI TTM FCF has increased by +$1.86 million (+14.98%).
- ATXI TTM FCF is now -1241.70% below its all-time high of -$789.00 thousand, reached on March 31, 2017.
Performance
ATXI TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ATXI Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -63.9% | -24.3% | +15.0% |
| 3 y3 years | -121.8% | -140.2% | -182.3% |
| 5 y5 years | +31.6% | -68.5% | +53.7% |
ATXI Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -232.0% | at low | -421.5% | +56.6% | -182.3% | +25.9% |
| 5 y | 5-year | -232.0% | +52.6% | -439.0% | +56.6% | -183.1% | +59.7% |
| alltime | all time | -662.9% | +52.6% | -8397.1% | +79.3% | -1241.7% | +59.7% |
Avenue Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.89 M(+28.2%) | -$10.59 M(+10.4%) |
| Jun 2024 | - | -$2.25 M(-27.8%) | -$9.59 M(-31.5%) |
| Mar 2024 | - | -$3.12 M(+34.3%) | -$14.00 M(+12.4%) |
| Dec 2023 | -$12.45 M(+63.9%) | -$2.32 M(+23.0%) | -$12.45 M(-12.9%) |
| Sep 2023 | - | -$1.89 M(-71.7%) | -$14.30 M(+10.3%) |
| Jun 2023 | - | -$6.67 M(+323.7%) | -$12.96 M(+79.0%) |
| Mar 2023 | - | -$1.57 M(-62.3%) | -$7.24 M(-4.7%) |
| Dec 2022 | -$7.60 M(+102.6%) | -$4.17 M(+652.5%) | -$7.60 M(+64.1%) |
| Sep 2022 | - | -$554.00 K(-41.3%) | -$4.63 M(+0.4%) |
| Jun 2022 | - | -$943.00 K(-51.1%) | -$4.61 M(+5.5%) |
| Mar 2022 | - | -$1.93 M(+60.4%) | -$4.37 M(+16.6%) |
| Dec 2021 | -$3.75 M(-33.2%) | -$1.20 M(+124.4%) | -$3.75 M(+0.3%) |
| Sep 2021 | - | -$536.00 K(-23.9%) | -$3.74 M(-9.6%) |
| Jun 2021 | - | -$704.00 K(-46.1%) | -$4.14 M(-12.9%) |
| Mar 2021 | - | -$1.31 M(+9.6%) | -$4.75 M(-15.4%) |
| Dec 2020 | -$5.61 M | -$1.19 M(+28.0%) | -$5.61 M(-40.4%) |
| Sep 2020 | - | -$932.00 K(-29.2%) | -$9.42 M(-7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$1.32 M(-39.3%) | -$10.20 M(-55.4%) |
| Mar 2020 | - | -$2.17 M(-56.5%) | -$22.86 M(-12.9%) |
| Dec 2019 | -$26.26 M(+44.2%) | -$5.00 M(+191.5%) | -$26.26 M(+16.7%) |
| Sep 2019 | - | -$1.71 M(-87.7%) | -$22.50 M(-9.7%) |
| Jun 2019 | - | -$13.98 M(+151.1%) | -$24.92 M(+46.9%) |
| Mar 2019 | - | -$5.57 M(+349.8%) | -$16.96 M(-6.9%) |
| Dec 2018 | -$18.22 M(+167.8%) | -$1.24 M(-70.1%) | -$18.22 M(-14.3%) |
| Sep 2018 | - | -$4.14 M(-31.3%) | -$21.25 M(+11.9%) |
| Jun 2018 | - | -$6.02 M(-11.7%) | -$18.99 M(+39.8%) |
| Mar 2018 | - | -$6.82 M(+59.8%) | -$13.59 M(+99.8%) |
| Dec 2017 | -$6.80 M(+316.8%) | -$4.27 M(+127.1%) | -$6.80 M(+160.9%) |
| Sep 2017 | - | -$1.88 M(+202.6%) | -$2.61 M(+122.6%) |
| Jun 2017 | - | -$621.00 K(+1726.5%) | -$1.17 M(+48.4%) |
| Mar 2017 | - | -$34.00 K(-53.4%) | -$789.00 K(-51.7%) |
| Dec 2016 | -$1.63 M | -$73.00 K(-83.5%) | -$1.63 M(+4.7%) |
| Sep 2016 | - | -$443.00 K(+85.4%) | -$1.56 M(+39.7%) |
| Jun 2016 | - | -$239.00 K(-72.7%) | -$1.12 M(+27.3%) |
| Mar 2016 | - | -$877.00 K | -$877.00 K |
FAQ
- What is Avenue Therapeutics annual free cash flow?
- What is the all time high annual FCF for Avenue Therapeutics?
- What is Avenue Therapeutics annual FCF year-on-year change?
- What is Avenue Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Avenue Therapeutics?
- What is Avenue Therapeutics quarterly FCF year-on-year change?
- What is Avenue Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Avenue Therapeutics?
- What is Avenue Therapeutics TTM FCF year-on-year change?
What is Avenue Therapeutics annual free cash flow?
The current annual FCF of ATXI is -$12.45 M
What is the all time high annual FCF for Avenue Therapeutics?
Avenue Therapeutics all-time high annual free cash flow is -$1.63 M
What is Avenue Therapeutics annual FCF year-on-year change?
Over the past year, ATXI annual free cash flow has changed by -$4.86 M (-63.92%)
What is Avenue Therapeutics quarterly free cash flow?
The current quarterly FCF of ATXI is -$2.89 M
What is the all time high quarterly FCF for Avenue Therapeutics?
Avenue Therapeutics all-time high quarterly free cash flow is -$34.00 K
What is Avenue Therapeutics quarterly FCF year-on-year change?
Over the past year, ATXI quarterly free cash flow has changed by -$565.00 K (-24.31%)
What is Avenue Therapeutics TTM free cash flow?
The current TTM FCF of ATXI is -$10.59 M
What is the all time high TTM FCF for Avenue Therapeutics?
Avenue Therapeutics all-time high TTM free cash flow is -$789.00 K
What is Avenue Therapeutics TTM FCF year-on-year change?
Over the past year, ATXI TTM free cash flow has changed by +$1.86 M (+14.98%)